Loading...

Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications

The PI3K/AKT/mTOR pathway plays a crucial role in the development of leiomyosarcomas (LMSs). In this study, we tested the efficacy of dual PI3K/mTOR (BEZ235), PI3K (BKM120) and mTOR (everolimus) inhibitors in three human LMS cell lines. In vitro and in vivo studies using LMS cell lines showed that B...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Fourneaux, Benjamin, Chaire, Vanessa, Lucchesi, Carlo, Karanian, Marie, Pineau, Raphael, Laroche-Clary, Audrey, Italiano, Antoine
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352367/
https://ncbi.nlm.nih.gov/pubmed/28002802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13987
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!